脳を遮断する:の治療におけるNrf2-ARE経路

Arshdeep Kaur¹, Navpreet Kaur¹, Shamsher Singh²

¹Department of Pharmacy Practice, ISF College of Pharmacy (An Autonomous College), Moga-142001, Punjab, India.

Central nervous system agents in medicinal chemistry

|August 28, 2025

まとめ

,特に側頭葉のは,酸化ストレスを含みます. Nrf2経路をターゲットにすることで,酸化損傷を軽減し,発作患者の神経生存率を向上させることで,新しい治療法を提供することができる.

科学分野:

神経科学
細胞生物学
病理生理学

背景:

は世界で6500万人に発作や認知障害を引き起こします
テンポラル・ロブ・エピレプシー (TLE) は,治療にもかかわらず30%の患者で症状が持続する焦点性エピレプシーです.
反応性酸素種 (ROS) によって引き起こされる酸化ストレス (OS) は,の発症と神経損傷の鍵です.

研究の目的:

エピレプシーにおける酸化ストレスの役割を探るため
治療対象としてNrf2経路の可能性を調査する.

主な方法:

酸化ストレスとに関する現在の研究のレビュー
細胞防御における Nrf2 抗酸化反応要素 (ARE) 信号経路の役割の分析
エピレプシーの治療のためのNrf2活性化化合物の研究の検討.

主要な成果:

酸化ストレスとROSの過剰生産は,神経機能障害との死亡に寄与する.
Nrf2は細胞の抗酸化防御の重要なレギュラーです.
Nrf2経路の活性化により,抗酸化物質の発現が促進され,神経細胞が保護されます.

結論:

Nrf2を標的とした治療は発作に対する有望な治療戦略です
Nrf2の活性化により,OSが低下し,神経生存率が改善される可能性があります.
Nrf2活性化化合物の開発は,新しい抗療法につながる可能性があります.

キーワード:

エピレプシー Nrf2アクティベーター Nrf2-ARE経路について抗酸化反応の要素神経保護酸化ストレス

さらに関連する動画

10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

7.1K

09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.5K

関連する概念動画

01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

635

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

635

01:24

Epilepsy and Seizures: Overview

275

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

275

02:26

NF-κB-dependent Signaling Pathway

7.8K

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

7.8K

01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

445

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

445

01:14

Antiepileptic Drugs: Glutamate Antagonists

511

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

511

01:20

Antiepileptic Drugs: Potassium Channel Activators

274

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

274

関連する実験動画